flow trial semaglutide nejm 🔴Cardiovascular outcomes with by severity of chronic kidney disease in type 2 diabetes: the trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants In the SURMOUNT-5 phase 3b

Horton JD, Shimano H, Hamilton RL, Brown MS, Goldstein JL (1999) Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL

dose reduction resolves this Blood sugar changes: GH antagonizes insulin

Significant weight loss typically occurs over several months, especially when paired with lifestyle changes

NG239 Vitamin B12 deficiency in over 16s: diagnosis and management risk factors and symptoms

When Zepbound (Tirzepatide) is taken with insulin and the insulin dose is reduced too quickly, it can lead to high blood sugar (hyperglycemia), which increases the risk of diabetic ketoacidosis

Very low intake may worsen fatigue, reduce activity, increase constipation, and contribute to muscle loss